Inici › Dermatomiositis › Illinois

Assaigs clínics de Dermatomiositis a Illinois

3 estudis de Dermatomiositis busquen participants en centres de Illinois.

Text oficial de l'estudi (anglès)

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

Research Site, Willowbrook

ReclutantFase 3

Edats de 18 a 75 · Tots els sexes · Actualitzat el 24 de set. 2026 · NCT06455449

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Ann & Robert H. Lurie Children's Hospital of Chicago - Accepting Young Adult and Juvenile Patients, Chicago
Northwestern Memorial Hospital - Accepting Adult Patients, Chicago
The University of Chicago Medical Center - Accepting Adult and Juvenile Patients, Chicago

ReclutantFase 2/3

Edats de 6 a 75 · Tots els sexes · Actualitzat el 17 de set. 2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

The University of Chicago Medical Center, Chicago

ReclutantFase 1

Edats de 18 a 74 · Tots els sexes · Actualitzat el 10 de set. 2026 · NCT07085104

De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.